Literature DB >> 20036812

Growth factors in tumor microenvironment.

Xuejing Zhang1, Daotai Nie, Subhas Chakrabarty.   

Abstract

Tumor microenvironment plays a critical role in tumor initiation and progression. Components in the microenvironment can modulate the growth of tumor cells, their ability to progress and metastasize. A major venue of communication between tumor cells and their microenvironment is through polypeptide growth factors and receptors for these growth factors. This article discusses three major classes of growth-stimulatory polypeptide growth factors and receptors for these growth factors. It also discusses how deregulation of these growth factors or their receptors can drive malignant transformation and progression.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20036812      PMCID: PMC3409472          DOI: 10.2741/3612

Source DB:  PubMed          Journal:  Front Biosci (Landmark Ed)        ISSN: 2768-6698


  88 in total

Review 1.  Diversity within pericytes.

Authors:  D E Sims
Journal:  Clin Exp Pharmacol Physiol       Date:  2000-10       Impact factor: 2.557

Review 2.  The ErbB signaling network: receptor heterodimerization in development and cancer.

Authors:  M A Olayioye; R M Neve; H A Lane; N E Hynes
Journal:  EMBO J       Date:  2000-07-03       Impact factor: 11.598

Review 3.  New members of the platelet-derived growth factor family of mitogens.

Authors:  Carl-Henrik Heldin; Ulf Eriksson; Arne Ostman
Journal:  Arch Biochem Biophys       Date:  2002-02-15       Impact factor: 4.013

Review 4.  Effects of growth factors and cytokines on osteoblast differentiation.

Authors:  Francis J Hughes; Wendy Turner; Georgios Belibasakis; Gianluca Martuscelli
Journal:  Periodontol 2000       Date:  2006       Impact factor: 7.589

5.  Pancreatic carcinoma cells induce fibrosis by stimulating proliferation and matrix synthesis of stellate cells.

Authors:  Max G Bachem; Marion Schünemann; Marco Ramadani; Marco Siech; Hans Beger; Andreas Buck; Shaoxia Zhou; Alexandra Schmid-Kotsas; Guido Adler
Journal:  Gastroenterology       Date:  2005-04       Impact factor: 22.682

6.  Gefitinib inhibits the ability of human bone marrow stromal cells to induce osteoclast differentiation: implications for the pathogenesis and treatment of bone metastasis.

Authors:  N Normanno; A De Luca; D Aldinucci; M R Maiello; M Mancino; A D'Antonio; R De Filippi; A Pinto
Journal:  Endocr Relat Cancer       Date:  2005-06       Impact factor: 5.678

7.  Association of epidermal growth factor receptor (EGFR) gene mutations with EGFR amplification in advanced non-small cell lung cancer.

Authors:  Ryotaro Morinaga; Isamu Okamoto; Yoshihiko Fujita; Tokuzo Arao; Masaru Sekijima; Kazuto Nishio; Hiroyuki Ito; Masahiro Fukuoka; Jun-Ichi Kadota; Kazuhiko Nakagawa
Journal:  Cancer Sci       Date:  2008-10-16       Impact factor: 6.716

Review 8.  Role of Rho GTPases in breast cancer.

Authors:  Yong Tang; Lola Olufemi; Man-Tzu Wang; Daotai Nie
Journal:  Front Biosci       Date:  2008-01-01

Review 9.  The organizing principle: microenvironmental influences in the normal and malignant breast.

Authors:  Mina J Bissell; Derek C Radisky; Aylin Rizki; Valerie M Weaver; Ole W Petersen
Journal:  Differentiation       Date:  2002-12       Impact factor: 3.880

10.  Peripheral lymph node stromal cells can promote growth and tumorigenicity of breast carcinoma cells through the release of IGF-I and EGF.

Authors:  Christina LeBedis; Keguan Chen; Lucia Fallavollita; Tarek Boutros; Pnina Brodt
Journal:  Int J Cancer       Date:  2002-07-01       Impact factor: 7.396

View more
  24 in total

Review 1.  Regulation of invadopodia by the tumor microenvironment.

Authors:  Christine M Gould; Sara A Courtneidge
Journal:  Cell Adh Migr       Date:  2014       Impact factor: 3.405

2.  TGFβ signaling confers sorafenib resistance via induction of multiple RTKs in hepatocellular carcinoma cells.

Authors:  Nathan Ungerleider; Chang Han; Jinqiang Zhang; Lu Yao; Tong Wu
Journal:  Mol Carcinog       Date:  2016-11-25       Impact factor: 4.784

3.  Avascular tumour growth models based on anomalous diffusion.

Authors:  Sounak Sadhukhan; S K Basu
Journal:  J Biol Phys       Date:  2020-03-17       Impact factor: 1.365

4.  Variable Effects of Growth Factors on Developmental Gene Expression in Pancreatic Cancer Cells.

Authors:  D A Gnatenko; E P Kopantzev; E D Sverdlov
Journal:  Dokl Biochem Biophys       Date:  2018-08-31       Impact factor: 0.788

Review 5.  Circulating tumor cells in oral squamous cell carcinoma-an enigma or reality?

Authors:  N Anitha; Sudha Jimson; K M K Masthan; J Jenita Jacobina
Journal:  J Pharm Bioallied Sci       Date:  2015-04

6.  Evolutionarily stable anti-cancer therapies by autologous cell defection.

Authors:  Marco Archetti
Journal:  Evol Med Public Health       Date:  2013-07-16

7.  Pharmacologic activity and pharmacokinetics of metabolites of regorafenib in preclinical models.

Authors:  Dieter Zopf; Iduna Fichtner; Ajay Bhargava; Wolfram Steinke; Karl-Heinz Thierauch; Konstanze Diefenbach; Scott Wilhelm; Frank-Thorsten Hafner; Michael Gerisch
Journal:  Cancer Med       Date:  2016-10-13       Impact factor: 4.452

8.  Immune microenvironment in tumor progression: characteristics and challenges for therapy.

Authors:  Valerie Chew; Han Chong Toh; Jean-Pierre Abastado
Journal:  J Oncol       Date:  2012-08-08       Impact factor: 4.375

Review 9.  Detecting circulating tumor cells: current challenges and new trends.

Authors:  Bin Hong; Youli Zu
Journal:  Theranostics       Date:  2013-04-23       Impact factor: 11.556

10.  Sulfatide interacts with and activates integrin αVβ3 in human hepatocellular carcinoma cells.

Authors:  Rong Wang; Bing Qi; Yi Wei Dong; Qian Qian Cai; Nian Hui Deng; Qi Chen; Chao Li; Yu Tong Jin; Xing Zhong Wu
Journal:  Oncotarget       Date:  2016-06-14
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.